CMRF-44 antibody-mediated depletion of activated human dendridic cells: a potential means for improving allograft survival1

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Transplantation

• Publication date

  2003-05-27

• Fields of study

  Medicine

• Identifiers
  DOI 10.1097/01.TP.0000062569.40977.66PMID 12777863
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Single step enrichment of blood dendritic cells by positive immunoselection.

  2003cited by this paper
• DCs and peripheral T cell tolerance.

  2001cited by this paper
• Treatment of steroid-refractory acute graft-versus-host disease with anti-CD147 monoclonal antibody ABX-CBL.

  2001cited by this paper
• Phenotypic characterization of five dendritic cell subsets in human tonsils.

  2001cited by this paper
• Surgical and physical stress increases circulating blood dendritic cell counts independently of monocyte counts.

  2001cited by this paper
• Blockade of CD86 and CD40 induces alloantigen-specific immunoregulatory T cells that remain anergic even after reversal of hyporesponsiveness.

  2000cited by this paper
• Granulocyte-colony stimulating factor mobilizes T helper 2-inducing dendritic cells.

  2000cited by this paper
• Plasmacytoid dendritic cells activated by influenza virus and CD40L drive a potent TH1 polarization

  2000cited by this paper
• Are dendritic cells the key to liver transplant tolerance?

  1999cited by this paper
• Reciprocal control of T helper cell and dendritic cell differentiation.

  1999cited by this paper
• Monitoring human blood dendritic cell numbers in normal individuals and in stem cell transplantation.

  1999cited by this paper
• Treatment with humanized monoclonal antibody against CD154 prevents acute renal allograft rejection in nonhuman primates

  1999cited by this paper
• Transplant surgery injury recruits recipient MHC class II-positive leukocytes into the kidney.

  1999cited by this paper
• Expression of the RelB transcription factor correlates with the activation of human dendritic cells

  1999cited by this paper
• Transplantation of anergic histoincompatible bone marrow allografts.

  1999influential reference
• Prevention of graft versus host disease by inactivation of host antigen-presenting cells.

  1999influential reference
• Peritransplant tolerance induction in macaques: early events reflecting the unique synergy between immunotoxin and deoxyspergualin.

  1999cited by this paper
• Human dendritic cells express a 95 kDa activation/differentiation antigen defined by CMRF-56.

  1999cited by this paper
• Dermal dendritic cells associated with T lymphocytes in normal human skin display an activated phenotype.

  1998cited by this paper
• Dendritic Cells: Unique Leukocyte Populations Which Control the Primary

  1997cited by this paper
• Dendritic cells: unique leukocyte populations which control the primary immune response.

  1997cited by this paper
• The Enigmatic Plasmacytoid T Cells Develop into Dendritic Cells with Interleukin (IL)-3 and CD40-Ligand

  1997cited by this paper
• Isolation of human blood dendritic cells using the CMRF-44 monoclonal antibody: implications for studies on antigen-presenting cell function and immunotherapy.

  1997cited by this paper
• Augmentation of dendritic cells in murine organ donors by Flt3 ligand alters the balance between transplant tolerance and immunity.

  1997cited by this paper
• Complete blockade of B7 family-mediated costimulation is necessary to induce human alloantigen-specific anergy: a method to ameliorate graft-versus-host disease and extend the donor pool.

  1996cited by this paper
• Human blood dendritic cells selectively express CD83, a member of the immunoglobulin superfamily.

  1995cited by this paper
• TREATMENT OF ACUTE GRAFT‐VERSUS-HOST DISEASE WITH METHYLPREDNISOLONE AND CYCLOSPORINE WITH OR WITHOUT AN ANTI‐INTERLEUKIN-2 RECEPTOR MONOCLONAL ANTIBODY: A Multicenter Phase III Study

  1995cited by this paper
• Coblockade of the LFA1:ICAM and CD28/CTLA4:B7 pathways is a highly effective means of preventing acute lethal graft-versus-host disease induced by fully major histocompatibility complex-disparate donor grafts.

  1995cited by this paper
• Characterization of CMRF-44, a novel monoclonal antibody to an activation antigen expressed by the allostimulatory cells within peripheral blood, including dendritic cells.

  1994cited by this paper
• Depletion of donor kidney dendritic cells prolongs graft survival.

  1984cited by this paper
• THE EFFECT OF DONOR PRETREATMENT ON INTERSTITIAL DENDRITIC CELL CONTENT AND RAT CARDIAC ALLOGRAFT SURVIVAL

  1984cited by this paper
• Prevention of rejection of murine islet allografts by pretreatment with anti-dendritic cell antibody.

  1984cited by this paper

• Antibody to the dendritic cell surface activation antigen CD83 prevents acute graft-versus-host disease

  2009cites this paper
• Antibody to the dendritic cell surface activation antigen CD83 prevents acute graft-versus-host disease

  2009cites this paper
• Presentation of human T cell leukemia virus type 1 (HTLV‐1) Tax protein by dendritic cells: the underlying mechanism of HTLV‐1‐associated neuroinflammatory disease

  2009cites this paper
• Dendritic cell depletion for acute GvHD

  2009cites this paper
• Immunosuppression by mesenchymal stromal cells: from culture to clinic.

  2008cites this paper
• Activated Circulating Dendritic Cells After Hematopoietic Stem Cell Transplantation Predict Acute Graft-Versus-Host Disease

  2007cites this paper
• Enhanced delivery of immunoliposomes to human dendritic cells by targeting the multilectin receptor DEC-205.

  2007cites this paper
• In Vitro Depletion of Tissue-Derived Dendritic Cells by CMRF-44 Antibody and Alemtuzumab: Implications for the Control of Graft-Versus-Host Disease

  2005cites this paper
• Manipulation of dendritic cells in organ transplantation: a major step towards graft tolerance?

  2004cites this paper
• Dendritic cell pathology

  2004cites this paper
• Methode d'immunomodulation

  2003cites this paper